Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Diabetes and infectious disease mortality in Mexico City.

Journal article

Bragg F. et al, (2023), BMJ open diabetes research & care, 11

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults.

Journal article

Aguilar-Ramirez D. et al, (2022), Commun Med (Lond), 2

Empagliflozin in Patients with Chronic Kidney Disease.

Journal article

EMPA-KIDNEY Collaborative Group None. et al, (2022), N Engl J Med

Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults.

Journal article

Kartsonaki C. et al, (2022), Int J Epidemiol, 51, 817 - 829

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study.

Journal article

Pang Y. et al, (2022), Am J Clin Nutr, 115, 799 - 810

Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults.

Journal article

Bragg F. et al, (2022), Diabetes Care, 45, 477 - 480

Load More